Actively Recruiting

Phase 1
Age: 18Years +
All Genders
NCT07063693

ABY-029 Glioma Trial

Led by Dartmouth-Hitchcock Medical Center · Updated on 2026-03-10

33

Participants Needed

1

Research Sites

149 weeks

Total Duration

On this page

Sponsors

D

Dartmouth-Hitchcock Medical Center

Lead Sponsor

D

Dartmouth College

Collaborating Sponsor

AI-Summary

What this Trial Is About

The purposes of the research trial are to study the safety of ABY-029 and to understand how much of the drug is needed to reach brain tumors so it can be visualized best by surgeons. Investigators will do this by comparing two groups of participants that receive different, very small amounts of ABY-029. Investigators will use an imaging system during surgery to record the amount of ABY-029 in the participant's tumor and in the surrounding tissue.

CONDITIONS

Official Title

ABY-029 Glioma Trial

Who Can Participate

Age: 18Years +
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Clinical diagnosis of presumed high-grade glioma based on imaging data
  • Tumor planned for open cranial resection
  • Valid informed consent given by participant
  • Age 18 years or older
  • Ability to understand and willingness to sign informed consent document
Not Eligible

You will not qualify if you...

  • Prisoners
  • Pregnant or breastfeeding individuals
  • Participants on any experimental or approved anti-EGFR targeted therapies
  • Elevated kidney or liver function tests greater than 2.5 times normal within 30 days before surgery
  • Any condition that contraindicates research participation as judged by the clinical investigator

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 1 location

1

Dartmouth-Hitchcock Medical Center

Lebanon, New Hampshire, United States, 03756

Actively Recruiting

Loading map...

Research Team

K

Keith D Paulsen, PhD

CONTACT

L

Linton Evans, MD

CONTACT

How is the study designed?

Study Type

INTERVENTIONAL

Masking

NONE

Allocation

NON_RANDOMIZED

Model

SINGLE_GROUP

Primary Purpose

DIAGNOSTIC

Number of Arms

2

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here